Literature DB >> 26725039

25-hydroxyvitamin D Levels and Coronary Heart Disease Risk Reclassification in Hypertension--Is it worth the "hype"?

Erin D Michos1, Pamela L Lutsey2.   

Abstract

Entities:  

Keywords:  Commentary; Coronary heart disease; Hypertension; Risk reclassification; Vitamin D

Mesh：

Substances：

Year:  2015        PMID： 26725039      PMCID： PMC5329752          DOI： 10.1016/j.atherosclerosis.2015.11.035

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  24 in total

1.  Free 25(OH)D and Calcium Absorption, PTH, and Markers of Bone Turnover.

Authors:  John Aloia; Ruban Dhaliwal; Mageda Mikhail; Albert Shieh; Alexandra Stolberg; Louis Ragolia; Melissa Fazzari; Steven A Abrams
Journal:  J Clin Endocrinol Metab       Date:  2015-08-27       Impact factor: 5.958

2.  Standardization of measurements of 25-hydroxyvitamin D3 and D2.

Authors:  Linda M Thienpont; Hedwig C M Stepman; Hubert W Vesper
Journal:  Scand J Clin Lab Invest Suppl       Date:  2012

3.  Screening for vitamin D deficiency in adults: U.S. Preventive Services Task Force recommendation statement.

Authors:  Michael L LeFevre
Journal:  Ann Intern Med       Date:  2015-01-20       Impact factor: 25.391

4.  The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease.

Authors:  Joann E Manson; Shari S Bassuk; I-Min Lee; Nancy R Cook; Michelle A Albert; David Gordon; Elaine Zaharris; Jean G Macfadyen; Eleanor Danielson; Jennifer Lin; Shumin M Zhang; Julie E Buring
Journal:  Contemp Clin Trials       Date:  2011-10-02       Impact factor: 2.226

5.  An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort.

Authors:  Andrew P DeFilippis; Rebekah Young; Christopher J Carrubba; John W McEvoy; Matthew J Budoff; Roger S Blumenthal; Richard A Kronmal; Robyn L McClelland; Khurram Nasir; Michael J Blaha
Journal:  Ann Intern Med       Date:  2015-02-17       Impact factor: 25.391

Review 6.  Vitamin D, calcium, and atherosclerotic risk: evidence from serum levels and supplementation studies.

Authors:  Pamela L Lutsey; Erin D Michos
Journal:  Curr Atheroscler Rep       Date:  2013-01       Impact factor: 5.113

7.  Vitamin D, vitamin D binding protein gene polymorphisms, race and risk of incident stroke: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  A L C Schneider; P L Lutsey; E Selvin; T H Mosley; A R Sharrett; K A Carson; W S Post; J S Pankow; A R Folsom; R F Gottesman; E D Michos
Journal:  Eur J Neurol       Date:  2015-05-12       Impact factor: 6.089

8.  Race and Vitamin D Binding Protein Gene Polymorphisms Modify the Association of 25-Hydroxyvitamin D and Incident Heart Failure: The ARIC (Atherosclerosis Risk in Communities) Study.

Authors:  Pamela L Lutsey; Erin D Michos; Jeffrey R Misialek; James S Pankow; Laura Loehr; Elizabeth Selvin; Jared P Reis; Myron Gross; John H Eckfeldt; Aaron R Folsom
Journal:  JACC Heart Fail       Date:  2015-04-08       Impact factor: 12.035

9.  Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures.

Authors:  Nancy R Cook; Paul M Ridker
Journal:  Ann Intern Med       Date:  2009-06-02       Impact factor: 25.391

10.  Bioavailable vitamin D is more tightly linked to mineral metabolism than total vitamin D in incident hemodialysis patients.

Authors:  Ishir Bhan; Camille E Powe; Anders H Berg; Elizabeth Ankers; Julia B Wenger; S Ananth Karumanchi; Ravi I Thadhani
Journal:  Kidney Int       Date:  2012-03-07       Impact factor: 10.612
View more
  2 in total

Review 1.  Role of Vitamin D in Cardiovascular Diseases.

Authors:  Vikrant Rai; Devendra K Agrawal
Journal:  Endocrinol Metab Clin North Am       Date:  2017-09-29       Impact factor: 4.741

2.  Danshen (Salvia miltiorrhiza) Compounds Improve the Biochemical Indices of the Patients with Coronary Heart Disease.

Authors:  Boyan Liu; Yanhui Du; Lixin Cong; Xiaoying Jia; Ge Yang
Journal:  Evid Based Complement Alternat Med       Date:  2016-06-05       Impact factor: 2.629
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.